Invion

Subscribe to receive announcements and updates from Invion.

New investors

Home

Announcements

Updates

Lato

Invion’s Exec Chair and CEO, Prof Thian Chew,  was invited by Hanlim Pharm and Dr.inB to tour the K-MEDI hub – a  high-tech medical industry park created by the South Korean government  to strategically support new drug development. Hanlim is aiming to  partner with K-MEDI to undertake development work on Photosoft™.

The K-MEDI hub spans over 43 hectares and houses research support and clinical trial centres. The South Korean government is positioning K-MEDI as a global medical R&D hub with the mission to bring innovations to market to support the transfer of knowledge and technologies from the lab to the high-value-added medical industry. 

Invion’s partner, Hanlim Pharma, is planning on using the hub to test and develop treatments for cancers using Photosoft. We are excited to be part of this important initiative with the aim of collaborating with international R&D partners!

South Korean Partnership Update